Roche Diagnostics Canada, a trailblazer in the healthcare field, is proud to introduce Accu-Chek Mobile, the first strip-free blood glucose monitoring device available on the market.

Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.

Bernard Chang, MD, a member of the Department of Neurology at Beth Israel Deaconess Medical Center and Assistant Professor of Neurology at Harvard Medical School, received the Dreifuss-Penry Epilepsy Award at the 63rd Annual Meeting of the American Academy of Neurology, held recently in Honolulu, HI.

Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra ™s drug discovery platform, Pharmacomer?„? Technology. The product candidates and technology platform will be transferred to a newly formed joint venture, NT Life Sciences (NT Life), co-owned by Kadmon and Nano Terra, which will act as the licensor and recipient of any licensing or royalty fees subject to the agreement. Terms of the agreement were not disclosed.

Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.